Quest Laboratories Ltd

Quest Laboratories Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 30 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 31 May 2026, providing investors with the latest insights into the company’s performance and outlook.

Quest Laboratories Ltd., a micro-cap pharmaceutical company with a market capitalisation of ₹190.00 crores, reported a mixed performance in Q4 FY26, with net profit standing at ₹2.87 crores—a decline of 28.78% quarter-on-quarter and 47.94% year-on-year. Whilst revenue showed modest sequential growth of 5.85%, reaching ₹32.40 crores, the company faced significant margin compression that raised concerns about operational efficiency and profitability sustainability.

Quest Laboratories Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 11 May 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 19 May 2026, providing investors with the most up-to-date insight into the company’s performance and outlook.

At Rs 103.90, sellers were still queuing — but there were no buyers willing to take the other side. Quest Laboratories Ltd locked at its lower circuit of 4.98% on 19 May 2026, with unfilled sell orders and a frozen price, reflecting persistent selling pressure in a micro-cap stock with limited liquidity.

At Rs 110.00, sellers were still queuing — but there were no buyers willing to take the other side. Quest Laboratories Ltd locked at its lower circuit of 5% on 18 May 2026, with unfilled sell orders and a frozen price, signalling persistent selling pressure in a micro-cap stock with limited liquidity.

At Rs 116.05, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Quest Laboratories Ltd locked at its upper circuit of 4.98% on 15 May 2026, with buyers queuing and no sellers willing to part with shares.

At Rs 110.00, Quest Laboratories Ltd locked at its lower circuit on 14 Jun 2026, reflecting a 4.92% decline within a 5% price band. Sellers were lined up to exit, but no buyers emerged to absorb the supply, resulting in a frozen price and unfilled sell orders.

At Rs 119.0, sellers were still queuing — but there were no buyers willing to take the other side. Quest Laboratories Ltd locked at its lower circuit of 3.57% on 12 May 2026, with unfilled sell orders and a frozen price.

At Rs 123.4, sellers were still queuing — but there were no buyers willing to take the other side. Quest Laboratories Ltd locked at its lower circuit of 4.97% on 11 Jun 2026, with unfilled sell orders and a frozen price.

At Rs 129.85, sellers were still queuing — but there were no buyers willing to take the other side. Quest Laboratories Ltd locked at its lower circuit of 4.98% on 8 May 2026, with unfilled sell orders and a frozen price.

Quest Laboratories Ltd is rated Strong Buy by MarketsMOJO. This rating was last updated on 05 May 2026, reflecting a positive reassessment of the stock’s potential. However, all fundamentals, returns, and financial metrics discussed here are current as of 08 May 2026, providing investors with the latest insights into the company’s performance and outlook.

At Rs 136.65, sellers were still queuing — but there were no buyers willing to take the other side. Quest Laboratories Ltd locked at its lower circuit of 4.97% on 07 May 2026, with unfilled sell orders and a frozen price, reflecting persistent selling pressure in a micro-cap stock with limited liquidity.

At Rs 143.90, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Quest Laboratories Ltd locked at its upper circuit of 5.0% on 06 May 2026, with buyers queuing and no sellers willing to part with shares.

At Rs 136.90, sellers were still queuing — but there were no buyers willing to take the other side. Quest Laboratories Ltd locked at its lower circuit of 5.0% on 05 May 2026, with unfilled sell orders and a frozen price.

At Rs 144.55, sellers were still queuing — but there were no buyers willing to take the other side. Quest Laboratories Ltd locked at its lower circuit of 4.68% on 4 May 2026, with unfilled sell orders and a frozen price.

Quest Laboratories Ltd has experienced a notable shift in its valuation parameters, moving from a very attractive to an attractive rating, reflecting evolving market perceptions amid robust financial performance and sector dynamics. This recalibration in price-to-earnings and price-to-book value metrics, alongside peer comparisons, offers investors a nuanced view of the company’s price attractiveness within the Pharmaceuticals & Biotechnology sector.

At Rs 152.6, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Quest Laboratories Ltd locked at its upper circuit of 5% on 30 Apr 2026, with buyers queuing and no sellers willing to part with shares.